These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9008248)

  • 1. Endothelial injury in transgenic (mRen-2)27 hypertensive rats.
    Strawn WB; Gallagher P; Dean RH; Ganten D; Ferrario CM
    Am J Hypertens; 1997 Jan; 10(1):51-7. PubMed ID: 9008248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential alteration in vascular structure of resistance arteries isolated from the cerebral and mesenteric vascular beds of transgenic [(mRen-2)27], hypertensive rats.
    Dunn WR; Gardiner SM
    Hypertension; 1997 May; 29(5):1140-7. PubMed ID: 9149679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats.
    Nickenig G; Laufs U; Schnabel P; Knorr A; Paul M; Böhm MP
    Br J Pharmacol; 1997 May; 121(1):134-40. PubMed ID: 9146897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors, endothelial cell turnover and lipid transport in atherogenesis.
    Lin SJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):309-16. PubMed ID: 9037845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypertensive Ren-2 transgenic rat TGR (mREN2)27 in hypertension research. Characteristics and functional aspects.
    Langheinrich M; Lee MA; Böhm M; Pinto YM; Ganten D; Paul M
    Am J Hypertens; 1996 May; 9(5):506-12. PubMed ID: 8735183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
    Tokita Y; Franco-Saenz R; Mulrow PJ
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic estrogen treatment in female transgenic (mRen2)27 hypertensive rats augments endothelium-derived nitric oxide release.
    Li P; Ferrario CM; Ganten D; Brosnihan KB
    Am J Hypertens; 1997 Jun; 10(6):662-70. PubMed ID: 9194513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial injury and leukocyte adherence in Häutchen preparations from coronary arteries and aorta of cynomolgus monkeys.
    Skantze HB; Kaplan J; Bondjers G; Manuck S; Pettersson K
    Atherosclerosis; 1998 Jan; 136(1):33-42. PubMed ID: 9544729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies.
    Moravski CJ; Skinner SL; Stubbs AJ; Sarlos S; Kelly DJ; Cooper ME; Gilbert RE; Wilkinson-Berka JL
    Am J Pathol; 2003 Jan; 162(1):151-60. PubMed ID: 12507898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene.
    Moriguchi A; Brosnihan KB; Kumagai H; Ganten D; Ferrario CM
    Am J Physiol; 1994 Apr; 266(4 Pt 2):R1273-9. PubMed ID: 8184972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressor role of angiotensin AT2 receptors in the (mRen-2)27 transgenic rat.
    Nishioka T; Morris M; Li P; Ganten D; Ferrario CM; Callahan MF
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):357-62. PubMed ID: 9544877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of area postrema in transgene hypertension.
    Averill DB; Matsumura K; Ganten D; Ferrario CM
    Hypertension; 1996 Mar; 27(3 Pt 2):591-7. PubMed ID: 8613209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA synthesis in isolated arteries of normotensive and hypertensive rats: effects of the endothelium.
    Schiffers PM; Fazzi GE; Janssen GM; Uitendaal MP; Struijker Boudier HA; De Mey JG
    J Hypertens; 1994 Mar; 12(3):245-50. PubMed ID: 8021477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vascular beta-adrenergic remodeling in rat transgenic model over-expressing endothelial beta3-adrenoceptors].
    Toumaniantz G; Seze C; Serpillon S; Menoret S; Tesson L; Anégone I; Gauthier C
    Arch Mal Coeur Vaiss; 2005; 98(7-8):836-40. PubMed ID: 16220757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High blood pressure maintenance in transgenic mRen-2 vs. Lyon genetically hypertensive rats.
    Lo M; Medeiros IA; Mullins JJ; Ganten D; Barres C; Cerutti C; Vincent M; Sassard J
    Am J Physiol; 1993 Jul; 265(1 Pt 2):R180-6. PubMed ID: 8342685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.
    Gardiner SM; March JE; Kemp PA; Mullins JJ; Bennett T
    Br J Pharmacol; 1995 Oct; 116(4):2237-44. PubMed ID: 8564254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian rhythms in renal function in hypertensive TGR(mRen-2)27 rats and their normotensive controls.
    Pons M; Schnecko A; Witte K; Lemmer B; Waterhouse JM; Cambar J
    Am J Physiol; 1996 Oct; 271(4 Pt 2):R1002-8. PubMed ID: 8897993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial vasoconstrictor prostanoids modulate contractions to acetylcholine and ANG II in Ren-2 rats.
    Noll G; Lang MG; Tschudi MR; Ganten D; Lüscher TF
    Am J Physiol; 1997 Jan; 272(1 Pt 2):H493-500. PubMed ID: 9038972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS.
    Brosnihan KB; Li P; Ganten D; Ferrario CM
    Am J Physiol; 1997 Dec; 273(6):R1908-15. PubMed ID: 9435644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-(1-7) is involved in the endothelium-dependent modulation of phenylephrine-induced contraction in the aorta of mRen-2 transgenic rats.
    Lemos VS; Côrtes SF; Silva DM; Campagnole-Santos MJ; Santos RA
    Br J Pharmacol; 2002 Apr; 135(7):1743-8. PubMed ID: 11934815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.